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Volume 61, Number 1 Abstracts 281Comment: The data once again emphasized that AKI following
endovascular aortic repair is an infrequent but morbid complication. For
both open and endovascular repair of the abdominal and thoracic aorta,
acute kidney injury portends a worse short and long-term outcome even
if the patient does not become dialysis dependent.Safety and Efﬁcacy of a Potential Treatment Algorithm by
Using Manual Compression Repair and Ultrasound-Guided
Thrombin Injection for the Management of Iatrogenic
Femoral Artery Pseudoaneurysm in a Large Patient Cohort
Dzijan-Horn M, Langwieser N, Groha P, et al. Circ Cardiovasc Interv
2014;7:207-15.
Conclusions: A treatment algorithm incorporating both manual
compression repair and ultrasound-guided thrombin injection for manage-
ment of iatrogenic femoral artery pseudoaneurysm is both efﬁcacious and
safe.
Summary: When comparing ultrasound-guided manual compression
(USGC) and ultrasound-guided thrombin injection (UGTI), success of
USGC ranges between 71% and 99% but has disadvantages that include
less effectiveness in patients receiving anticoagulation, potentially long pro-
cedure times, and both patient and operator discomfort during compres-
sion. UGTI has higher success rates between 91% and 100% with a low
complication rate, but is an off-label use of thrombin. The authors devel-
oped at their institution in 2007 a treatment algorithm based on morpho-
logic properties of the pseudoaneurysm that they used to guide the use of
USGC or UGTI. In this paper they evaluate the safety and effectiveness
of their algorithm. The algorithm begins with ultrasound imaging of the
pseudoaneurysm. Pseudoaneurysms without a clearly deﬁnable neck and
those directly adjacent to vessels and pseudoaneurysms with a concomitant
arteriovenous ﬁstula were initially referred to USGC. Others were treated
with UGTI. Anticoagulation therapy was not halted routinely before treat-
ment and distal pulses were monitored before and after pseudoaneurysm
treatment. Between January 2007 and January 2011 a total of 432 pseudoa-
neurysms were diagnosed in 29,091 consecutive patients, (1.49%) of those
patients undergoing femoral artery catheterization. Closure devices were
not used. Based on the treatment algorithm there were 145 pseudoaneur-
ysms treated with USGC (34%) and 287 (66%) treated with UTGI.
Follow-up duplex scans were performed within 12 to 14 hours after
USGC only and within 4 to 6 hours after UGTI or by the next morning
and were available for 428 patients (99.1%). The overall success rate of
the institutional algorithm was 97.2% which was achieved by 178 manual
compressions treatments and 357 UGTI procedures, respectively. There
were procedural complications in ﬁve cases (1.4%) after UGTI and three
cases (1.7%) after USGC. The treatment algorithm was not successful in
12 patients; two pseudoaneurysms (0.5%) were subsequently successfully
excluded by implantation of a covered stent, and 10 patients required
surgical intervention (2.3%) which was associated with a complication rate
of 30%.
Comment: Both USGC and UGTI are now standard therapies for
femoral artery iatrogenic pseudoaneurysm. UGTI is preferred by most as
it is quicker, probably more effective, and involves less patient and oper-
ator discomfort. The most feared complication of UGTI is interarterial in-
jection of the thrombin or extension of the clot in the pseudoaneurym into
the femoral artery. The author’s treatment algorithm seeks to minimize
these potential complications. Three patients in this study treated with
UGTI had interarterial thromboembolism, two of which were successfully
treated with heparin only and the third required embolectomy from the
popliteal artery. The author’s treatment algorithm was associated with
an overall high success and low complication rate. It is likely however in
most practices USGC will be used less than described here. The author’s
treatment algorithm is, after all, to a great extent arbitrary. A more aggres-
sive approach with the use of UGTI may be possible with similar compli-
cation rates.Thirty-Year Mortality After Venous Thromboembolism: A
Population-Based Cohort Study
Søgaard KK, Schmidt M, Pedersen L, et al. Circulation 2014;130:829-36.
Conclusions: Patients with Venous Thromboembolism (VTE) are at
increased risk of dying, especially within the ﬁrst year after diagnosis. This
risk however continues after 30 years of follow-up and VTE in these patients
remains an important late cause of death.
Summary: Short-term mortality from VTE has been well studied,
however the magnitude of long-term mortality after VTE is found to vary
substantially between studies. One study reported an 8 year mortality risk
of 12% (Flinterman LE et al, PLoS Med 2012; 9:e1001155). An earlierstudy demonstrated a mortality risk that reached 50% after 8 years of
follow-up (Heit JA et al, Arch Intern Med 1999; 159:445-53). These
studies were, however, of restricted populations and had essentially little in-
formation of long-term mortality comparisons between VTE patients and a
comparison cohort from the general population. One other study has re-
ported a 40% higher mortality in VTE after 10 years compared with the ex-
pected mortality in the general population (Schulman S et al, J Thromb
Haemost 2006; 4:734-42). The authors therefore undertook a nationwide
population based cohort study to examine 30-year VTE mortality with
respect to VTE subtypes, calendar periods of diagnosis and underlying co-
morbidity. They used Danish medical databases with a total of 128,223 pa-
tients with ﬁrst time VTE (1980-2011) and a comparison cohort of
640,760 people from the general population, matched by sex, year of birth,
calendar period and without VTE for comparison. Mortality risk for patients
with deep venous thrombosis (DVT) and pulmonary embolism (PE) were
markedly higher than the comparison cohort during the ﬁrst year, especially
within the ﬁrst 30 days (3.0% and 31% vs 0.4%). Using Cox regression, mor-
tality rate ratios with 95% conﬁdence intervals were estimated. The overall
30-year mortality rate ratio (MRR) was 1.55 (95% conﬁdence interval
[CI], 1.53-1.57) for DVT and 2.77 (95% CI, 2.74-2.81) for PE. Thirty-
day MRR was 5.38 (95% CI, 5.00-5.80) for DVT and 80.87 (95% CI,
76.02-86.02) for PE. Over time, the 30-day MRR was consistently 5 to 6
fold increased for DVT whereas it improved for PE from 138 (95% CI,
125-153) in 1980-1989 to 36.08 (95% CI, 32.65-39.87) in 2000-2011.
The 1- to 10-year and 11- to 30-year MRRs remained 25% to 40% increased
after both DVT and PE but were 3 to 5 fold increased after DVT and 6 to
11 fold increased after PE when VTE was considered the immediate cause
of death.
Comment: This is fascinating data on the long-term mortality risk of
VTE. Vascular surgeons evaluating the effect of long-term VTE have tradi-
tionally focused on the development of chronic venous insufﬁciency. How-
ever like intermittent claudication the risk to the extremity in a patient with
VTE may be dwarfed by the risk to life. The study points out that it is
important to focus on optimizing treatment of VTE in reducing risk factors
for VTE reoccurrence to potentially improve patient mortality over time and
to prevent long-term VTE related death.Silent Cerebral Ischemia After Thoracic Endovascular
Aortic Repair: A Neuroimaging Study
Kahlert P, Eggebrecht H, Jánosi RA, et al. Ann Thorac Surg 2014;98:53-8.
Conclusions: Thoracic endovascular aortic repair (TEVAR) results
in high incidence of new foci of restricted diffusion on cerebral DW-
MRI with a pattern of diffusion deﬁcits suggesting periprocedural
embolization.
Summary: Periprocedural stroke after TEVAR is thought to be
related to emboli which are dislodged during manipulation of guidewires,
catheters, and delivery devices in a diseased aortic arch. It is possible, how-
ever, that in addition to clinically apparent disabling neurologic deﬁcits,
manipulations may also result in clinically silent cerebral embolization.
These silent emboli may be associated with more lingering neurologic
impairment and result in decline of cognitive function and worsening of
dementia during long-term follow-up (Bendszus M et al, Lancet Neurol
2006; 5:364-72). The authors sought to determine the incidence of clin-
ically silent cerebral embolism after TEVAR, postulating that the rate of
clinically silent cerebral ischemia may be higher than that of the clinically
evident cerebral ischemia rates of 2% to 6%. In this study19 patients (13
males and six females) who underwent TEVAR were included into a
descriptive study. Periprocedural apparent and silent cerebral ischemia
were assessed by daily clinical neurologic assessment and serial cerebral
diffusion-weighted magnetic resonance imaging (DW-MRI) at baseline
and 5 days (median interquartile range, 3.5) after the procedure. TEVAR
was successful in all patients without immediately clinically, apparent
neurologic deﬁcits. Post interventional cerebral DW-MRI detected a total
of 29 new foci of restricted diffusion in 12 of 19 TEVAR patients (63%).
Lesions were usually multiple (1 to 6 lesions per patient) and ranged in size
between 15 mm3 to 300 mm3; 16 lesions were found in the left hemi-
sphere, 13 lesions in the right hemisphere. Covering the left subclavian ar-
tery was performed in eight cases, but was not associated with
lateralization of lesions. There were no additional apparent neurologic
events during the in-hospital period.
Comment: Clearly, it is not optimal to be scraping catheters, guide-
wires and sheaths around in the aortic arch. The long-term effects of cere-
bral micro emboli occurring after all types of vascular procedures, including
coronary artery bypass, aortic arch repair, carotid endarterectomy, carotid
artery stenting and now TEVAR still remain to be determined. Neverthe-
less, one has to agree that the DWI lesions seen in this study cannot possibly
be good things.
